Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Need of Ranibizumab Injections With or Without Early Targeted Peripheral Laser Photocoagulation for Treatment of Macular Edema Due to Central Retinal Vein Occlusion

NCT04444492 is registered in ClinicalTrials.gov with University of Giessen as lead sponsor.

NCT NCT04444492
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444492 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Need of Ranibizumab Injections With or Without Early Targeted Peripheral Laser Photocoagulation for Treatment of Macular Edema Due to Central Retinal Vein Occlusion
Lead sponsor
University of Giessen
Phase
Phase 3
Overall status
Active, not recruiting
Start date
August 25, 2020
Completion date
November 30, 2027
Enrollment
88 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion with macular edema